ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,071, issued on March 11, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"Anti-TNF alpha antibody formulations" was invented by William J. Callahan (Thousand Oaks, Calif.), Rahul Rajan Kaushik (Newbury Park, Calif.) and Joy Brennan (Thousand Oaks, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Stable adalimumab formulations are disclosed."
The patent was filed on Aug. 19, 2022, under Application No. 17/820,958.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12247071&OS...